YU60896A - Antagonisti receptora nadražujuće aminokiseline - Google Patents

Antagonisti receptora nadražujuće aminokiseline

Info

Publication number
YU60896A
YU60896A YU60896A YU60896A YU60896A YU 60896 A YU60896 A YU 60896A YU 60896 A YU60896 A YU 60896A YU 60896 A YU60896 A YU 60896A YU 60896 A YU60896 A YU 60896A
Authority
YU
Yugoslavia
Prior art keywords
compound
formula
receptor antagonists
pharmaceutically acceptable
phenyl
Prior art date
Application number
YU60896A
Other languages
English (en)
Inventor
Dominiguez-Fernandez Carmen
Reed Helton David
Marc Massey Steven
Allen Monn James
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605430.9A external-priority patent/GB9605430D0/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU60896A publication Critical patent/YU60896A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pronađeno je jedinejnje formule I gde R predstavlja benzil ili difenilmetil grupu u kojoj je svaki fenilni prsten nesupstituisan ili supstituisan sa jednim, dva ili tri supstituenta izabranih nezavisno između fluora, hlora, metil, izopropil, metoksi, trifluormetil, trifluormetoksi, tetrafluoretoksi, fenil, fenoksi, 3-trifluormetilfenil i 4-hlorfenoksi. Dat je postupak za dobijanje jedinjenja formule I koji uključuje hidrolizu jedinjenje formule i skidanje zaštite sa jedinjenja formule, rastvaranje i prevođenje jedinjenja u netoksični metabolički labilni estar ili njegov amid i u farmaceutski prihvatljivu so. Farmaceutska formulacija uključuje farmaceutski prihvatljive nosače, razblaživače ili prihvatače.
YU60896A 1995-11-16 1996-11-15 Antagonisti receptora nadražujuće aminokiseline YU60896A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US687195P 1995-11-16 1995-11-16
GBGB9605430.9A GB9605430D0 (en) 1996-03-15 1996-03-15 Excitatory amino acid receptor antagonists

Publications (1)

Publication Number Publication Date
YU60896A true YU60896A (sh) 1998-12-23

Family

ID=26308934

Family Applications (1)

Application Number Title Priority Date Filing Date
YU60896A YU60896A (sh) 1995-11-16 1996-11-15 Antagonisti receptora nadražujuće aminokiseline

Country Status (13)

Country Link
EP (1) EP0774455A1 (sh)
JP (1) JP2000500752A (sh)
KR (1) KR19990067597A (sh)
CN (1) CN1202103A (sh)
AR (2) AR004600A1 (sh)
AU (1) AU703093B2 (sh)
BR (1) BR9611521A (sh)
CA (1) CA2237598A1 (sh)
CO (1) CO4750811A1 (sh)
EA (1) EA000894B1 (sh)
TW (1) TW427973B (sh)
WO (1) WO1997017950A1 (sh)
YU (1) YU60896A (sh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001515839A (ja) 1997-07-18 2001-09-25 ジョージタウン・ユニバーシティ 二環式向代謝性グルタミン酸受容体リガンド
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
SI1064256T1 (en) * 1998-03-17 2004-10-31 Pfizer Products Inc. Bicyclo (2.2.1) heptanes and related compounds
US6136861A (en) * 1998-03-17 2000-10-24 Pfizer Inc Bicyclo[2.2.1]heptanes and related compounds
EP1110943B1 (en) 1998-08-31 2004-06-16 Taisho Pharmaceutical Co. Ltd. 6-fluorobicyclo 3. 1.0]hexane derivatives
CH694053A5 (de) * 1998-09-03 2004-06-30 Hoffmann La Roche Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
NZ533699A (en) 2001-12-27 2006-05-26 Taisho Pharmaceutical Co Ltd 6-fluorobicyclo[3.1.0]hexane derivatives
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
WO2012068041A1 (en) * 2010-11-18 2012-05-24 Eli Lilly And Company 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS
AR083845A1 (es) 2010-11-18 2013-03-27 Lilly Co Eli COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR2/3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981880A (en) * 1969-03-14 1976-09-21 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
CA1278577C (en) * 1985-11-18 1991-01-02 Tatsuo Tsuri Bicyclic sulfonamide derivatives
PL182285B1 (pl) 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
EP0776201B1 (en) * 1994-08-12 2001-10-17 Eli Lilly And Company Treating anxiety
AU3325095A (en) * 1994-08-12 1996-03-07 Eli Lilly And Company Composition and method for protection against drug dependency

Also Published As

Publication number Publication date
WO1997017950A1 (en) 1997-05-22
TW427973B (en) 2001-04-01
EP0774455A1 (en) 1997-05-21
AR004601A1 (es) 1998-12-16
JP2000500752A (ja) 2000-01-25
AU703093B2 (en) 1999-03-18
EA199800380A1 (ru) 1998-10-29
EA000894B1 (ru) 2000-06-26
AR004600A1 (es) 1998-12-16
AU7731096A (en) 1997-06-05
CN1202103A (zh) 1998-12-16
CA2237598A1 (en) 1997-05-22
CO4750811A1 (es) 1999-03-31
KR19990067597A (ko) 1999-08-25
BR9611521A (pt) 1999-06-29

Similar Documents

Publication Publication Date Title
RU2361870C2 (ru) Новые кумарины, их карбоксамидные производные, способы получения, композиции и применение
NO20006282D0 (no) Nye cyklosporiner
DE69919212D1 (de) Aromatische amiden
YU60896A (sh) Antagonisti receptora nadražujuće aminokiseline
ATE306261T1 (de) Antithrombosemittel
DE69931393D1 (de) Antithrombotische amide
DE69830504D1 (de) Antithrombotische mitteln
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
NO2006007I1 (no) (+)-(S)-2-(3-benzoylfenyl)-propionsyre-trometaminsalt(deksketoprofentrometamol)
DK0889875T3 (da) Cycloproylalkansyrederivater
CA2190973A1 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
EA199800794A1 (ru) Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения
HRP20020876B1 (en) Method for synthesis of perindopril and its pharmaceutically acceotable salts
RU95106675A (ru) 3-индолилпиперидины, способ их получения, фармацевтическая композиция и способ ее получения
RU94020400A (ru) Производные индола, способ их получения, фармацевтическая композиция, способ лечения головной боли
TW356468B (en) Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
UA72945C2 (uk) Сполука (варіанти), фармацевтична композиція, спосіб лікування (варіанти)
EP1491533A3 (en) Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors
ME00437B (me) Novi proces za sintezu n-/(s)-1- karboksibutil/-(s)- alaninskog estra i primjena u sintezi perindoprila
ATE344237T1 (de) Hydroxyacetamidobenzolsulfonamidderivate
NO982107L (no) Fremstilling av et salt av klavulansyre
GB1437868A (en) Arylpiperazinoalkyl esters
DE69402703D1 (de) 3-(INDOL-3-YL) PROPENSäURDERIVATE, DIE ALS NMDA- ANTAGONISTEN NÜTZLICH SIND
DE60335960D1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
RU95117103A (ru) Производные хинолинкарбоновой кислоты и способы их получения